Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

EQS-Adhoc: ProSiebenSat.1 Media SE: ProSiebenSat.1 sells Verivox to Moltiply
EQS-Adhoc: ProSiebenSat.1 Media SE: ProSiebenSat.1 sells Verivox to Moltiply
EQS-Adhoc: ProSiebenSat.1 Media SE: ProSiebenSat.1 sells Verivox to Moltiply
If You Bought 1 Share of Axon Enterprise at Its IPO, Here's How Many Shares You Would Own Now
If You Bought 1 Share of Axon Enterprise at Its IPO, Here's How Many Shares You Would Own Now

Axon Enterprise (NASDAQ: AXON), the leading manufacturer of police body cameras and Taser devices, trades at over $550 per share and is a potential candidate for a stock split.

Before considering

EQS-News: AUTO1 Group to be included in the STOXX Europe 600 Index:
EQS-News: AUTO1 Group to be included in the STOXX Europe 600 Index
EQS-News: AUTO1 Group to be included in the STOXX Europe 600 Index
EQS-News: FUCHS concludes financial year 2024 successfully with new EBIT-high
EQS-News: FUCHS concludes financial year 2024 successfully with new EBIT-high
EQS-News: FUCHS concludes financial year 2024 successfully with new EBIT-high
EQS-Adhoc: Nagarro SE: Resignation of the Chairperson of the Supervisory Board: https://upload.wikimedia.org/wikipedia/commons/0/0a/Nagarro_Horizontal_Light_400x100px_300dpi.png
EQS-Adhoc: Nagarro SE: Resignation of the Chairperson of the Supervisory Board
EQS-Adhoc: Nagarro SE: Resignation of the Chairperson of the Supervisory Board
EQS-Adhoc: Nagarro SE: Resignation of the Chairperson of the Supervisory Board: https://upload.wikimedia.org/wikipedia/commons/0/0a/Nagarro_Horizontal_Light_400x100px_300dpi.png
EQS-Adhoc: Nagarro SE: Resignation of the Chairperson of the Supervisory Board
EQS-Adhoc: Nagarro SE: Resignation of the Chairperson of the Supervisory Board
Why HealthEquity Stock Was Sliding This Week
Why HealthEquity Stock Was Sliding This Week

Over the past few days HealthEquity (NASDAQ: HQY) shares have been rather sickly. The health savings account (HSA) specialist's stock was rocked by a disappointing earnings report, and as a result

EQS-Adhoc: ProSiebenSat.1 Media SE approves proposed agreement with General Atlantic on the acquisition of its minority stakes in NuCom Group and ParshipMeet Group together with an intended sale of Verivox
EQS-Adhoc: ProSiebenSat.1 Media SE approves proposed agreement with General Atlantic on the acquisition of its minority stakes in NuCom Group and ParshipMeet Group together with an intended sale of Verivox
EQS-Adhoc: ProSiebenSat.1 Media SE approves proposed agreement with General Atlantic on the acquisition of its minority stakes in NuCom Group and ParshipMeet Group together with an intended sale of Verivox
EQS-Adhoc: freenet AG decides on share buyback programme for up to EUR 100 million
EQS-Adhoc: freenet AG decides on share buyback programme for up to EUR 100 million
EQS-Adhoc: freenet AG decides on share buyback programme for up to EUR 100 million
EQS-Adhoc: freenet AG decides on share buyback programme for up to EUR 100 million
EQS-Adhoc: freenet AG decides on share buyback programme for up to EUR 100 million
EQS-Adhoc: freenet AG decides on share buyback programme for up to EUR 100 million
4 Things You Need to Know if You Buy Moderna Stock Today
4 Things You Need to Know if You Buy Moderna Stock Today

It's been nearly five years since Moderna (NASDAQ: MRNA) emerged as a biotech industry disruptor, with its COVID-19 vaccine playing a landmark role in tackling the global pandemic in late 2020

1 Wall Street Analyst Thinks Norwegian Cruise Line Stock Is Going to $30. Is It a Buy Around $20?
1 Wall Street Analyst Thinks Norwegian Cruise Line Stock Is Going to $30. Is It a Buy Around $20?

One Wall Street analyst thinks investors can book some nice profits by investing in Norwegian Cruise Line (NYSE: NCLH) stock right now. That's because demand for booking cruise vacations looks to be

EQS-News: Krones increases dividend for 2024 financial year by 18% to €2.60 per share
EQS-News: Krones increases dividend for 2024 financial year by 18% to €2.60 per share
EQS-News: Krones increases dividend for 2024 financial year by 18% to €2.60 per share
EQS-News: Nemetschek Group: Strong revenue growth of 17% to 19% with continued high profitability expected in the financial year 2025
EQS-News: Nemetschek Group: Strong revenue growth of 17% to 19% with continued high profitability expected in the financial year 2025
EQS-News: Nemetschek Group: Strong revenue growth of 17% to 19% with continued high profitability expected in the financial year 2025
EQS-News: Nemetschek Group: Strong revenue growth of 17% to 19% with continued high profitability expected in the financial year 2025
EQS-News: Nemetschek Group: Strong revenue growth of 17% to 19% with continued high profitability expected in the financial year 2025
EQS-News: Nemetschek Group: Strong revenue growth of 17% to 19% with continued high profitability expected in the financial year 2025
Why Roku Stock Is Soaring Today
Why Roku Stock Is Soaring Today

Roku (NASDAQ: ROKU) stock is surging Wednesday. The streaming specialist's share price was up 9.2% as of 3:15 p.m. ET, and had been up as much as 10.5% earlier in the daily session.

Roku is getting

S&P 500 Sell-Off: Here's Why This ETF May Be the Smartest Way to Invest in the S&P 500 Right Now
S&P 500 Sell-Off: Here's Why This ETF May Be the Smartest Way to Invest in the S&P 500 Right Now

The Sun was shining brightly on the U.S. stock market over the past couple of years. Unfortunately, some clouds have made their way over to the market.

The S&P 500 -- the stock market's most

EQS-News: KION presents AI Control Tower at GTC in San José, California
EQS-News: KION presents AI Control Tower at GTC in San José, California
EQS-News: KION presents AI Control Tower at GTC in San José, California
Coty Hosts Expert Panel to Bust Beauty Myths and #UndefineBeauty
Coty Hosts Expert Panel to Bust Beauty Myths and #UndefineBeauty


Coty (NYSE: COTY) (Paris: COTY), one of the world’s largest beauty companies, with an iconic portfolio of brands across fragrance, color cosmetics, skin and body care, hosted a cross-industry

Beat the Nasdaq With This Cash-Gushing Dividend Stock
Beat the Nasdaq With This Cash-Gushing Dividend Stock

If you're looking for market-beating stocks, it can sometimes be good to travel a bit off the beaten path to find more unusual options. Innovative Industrial Properties (NYSE: IIPR) offers just such

Semtech Brings LoRaWAN® Expertise to Global Smart Grid Standards Forum
Semtech Brings LoRaWAN® Expertise to Global Smart Grid Standards Forum


Semtech Corporation (Nasdaq: SMTC), a high-performance semiconductor, Internet of Things (IoT) systems and cloud connectivity service provider, announced that Rémi Demerlé, marketing director of

Power Integrations Launches TinySwitch-5 ICs for High-Efficiency Power Supplies
Power Integrations Launches TinySwitch-5 ICs for High-Efficiency Power Supplies


APEC 2025 Power Integrations (NASDAQ: POWI), the leader in high-voltage integrated circuits for energy-efficient power conversion, today announced TinySwitch™-5, extending the output power of the

Stock Market Correction: 3 Top Vanguard ETFs to Buy to Help Protect Your Portfolio from Volatility
Stock Market Correction: 3 Top Vanguard ETFs to Buy to Help Protect Your Portfolio from Volatility

The stock market recently entered a correction phase, which is a decline of 10% or more from the recent peak. The S&P 500 (SNPINDEX: ^GSPC) just hit that level on Thursday, while the Nasdaq

3 Vanguard ETFs to Buy With $1,000 and Hold Forever
3 Vanguard ETFs to Buy With $1,000 and Hold Forever

Thanks to their extremely low management fees, Vanguard's exchange-traded funds (ETFs) are consistently on the radars of investors keen on maximizing the returns on their investments -- and not

Down 93%, Is It Finally Time to Buy Moderna?
Down 93%, Is It Finally Time to Buy Moderna?

As we near the five-year anniversary of the COVID-19 pandemic, it's a good time to revisit the drugmaker stock that was top of mind back then. A few years ago, Moderna (NASDAQ: MRNA) stock soared on